Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3525-3533
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3525
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3525
Figure 1 Clinical management of inflammatory bowel disease/primary sclerosing cholangitis patients before and after liver transplantation.
TNFα: Tumor necrosis factor alpha; IBD: Inflammatory bowel disease; LT: Liver transplantation; PSC: Primary sclerosing cholangitis; CRC: Colorectal cancer; CMV: Cytomegalovirus; 5-ASA: 5-aminosalicylates.
- Citation: Indriolo A, Ravelli P. Clinical management of inflammatory bowel disease in the organ recipient. World J Gastroenterol 2014; 20(13): 3525-3533
- URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3525.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3525